Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
OBJECTIVES: The purpose of this study was to validate the lower end of the putative therapeutic range of serum tacrine concentrations of 7-20 ng ml(-1) in the treatment of Alzheimer's disease. METHODS: The relationship between dose, steady-state serum tacrine concentrations and change in MMSE s...
Main Authors: | Roberts, C, Ford, J, Truman, C, Scott, M, Mäkelä, P, Wilcock, G |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
1998
|
פריטים דומים
-
Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
מאת: Forsyth, DR, et al.
יצא לאור: (1989) -
Serum concentrations of tacrine hydrochloride predict its adverse effects in Alzheimer's disease.
מאת: Ford, J, et al.
יצא לאור: (1993) -
TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
מאת: Wilcock, G
יצא לאור: (1990) -
PHARMACOKINETICS OF TACRINE HYDROCHLORIDE IN PATIENTS WITH DEMENTIA
מאת: Forsyth, D, et al.
יצא לאור: (1989) -
Can blood concentrations of tacrine hydrochloride (THA) predict the risk of adverse effects?
מאת: Ford, J, et al.
יצא לאור: (1993)